AnteoTech (ADO) investor relations material

Executive summary

• Achieved independent commercial-format cell-level validation of Ultranode™ 95 high silicon anode for military drone batteries, exceeding industry standards for energy density and cycle life.

• Launched new ABT product Anteo C and expanded product portfolio with three new offerings in FY2026, broadening the addressable LiB market.

• Secured new international distribution and collaboration agreements in Japan and South Korea, and completed the initial stage of a collaborative CLIA product development program with a global life sciences company.

• Raised approximately A$10.0 million through the full exercise of listed options, materially strengthening the cash position.

Financial highlights

• Cash balance at 30 June 2026 was A$11.2 million, up from A$3.291 million at 31 March 2026.

• Net cash outflows from operating activities for the quarter were A$1.585 million.

• Customer receipts totaled A$17,000 for the quarter, with an additional A$134,138 received post quarter-end.

• No bank debt, only lease and asset-finance liabilities.

• Payments to related parties during the quarter were A$159,000 for directors' fees.

Outlook and guidance

• Focus for the next quarter is on converting customer sample trials and evaluations into sales, growing the pipeline, and securing strategic partnerships or investment.

• Continued emphasis on launching the AnteoBind™ NXT CLIA Kit in the US, expanding sales in Japan and India, and progressing commercial agreements for ABT products.

• Ongoing support for Wyon's Ultranode™ 70 evaluations and advancing negotiations for Ultranode™ 95 JDAs.